Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Primary Dysautonomias 1Polycystic Ovary Syndrome 1Metabolic Syndrome 1Insulin Resistance 1Hyperandrogenism 1

Interventions

Metformin 4Magnetic Resonance Spectroscopy 2Exercise 2Ethinyl Estradiol 2drospirenone and ethinyl estradiol combination 1drospirenone 1Walking 1Sugars 1Spironolactone 1Preoperative Exercise 1Phlebotomy 1Pancreaticoduodenectomy 1Inositol 1Hepatectomy 1Flutamide 1Diet, Reducing 1Diet, Mediterranean 1Diet, Fat-Restricted 1Diet Therapy 1Diet 1Diathermy 1Cyproterone Acetate 1Caloric Restriction 1Bloodletting 1Blood Pressure 1Blood Donation 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Metabolic Syndrome × Bloodletting × Clear all
NCT02460445 2022-07-27

Phlebotomy and Polycystic Ovary Syndrome

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Phase NA Completed
37 enrolled

Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism, Metabolic Syndrome, Primary Dysautonomias

Data powered by HemOnc (CC BY 4.0) Colophon âš¡